اخبار و اعلانات

 آمار

تعداد نشریات283
تعداد نشریات سازمان81
تعداد شماره‌ها2,726
تعداد مقالات31,042
تعداد مشاهده مقاله28,129,627
تعداد دریافت فایل اصل مقاله16,249,207
Karim Abdul-Husseein, H, Akram Al- Akkam, K, Karim Abdul-Husseein, M, Abdul-Amir Makki Al-Hindy, H. (1401). Liver Function Abnormalities in COVID-19 Patients and their Association with Age and Sex: a Cross-Sectional Study. سامانه مدیریت نشریات علمی, 78(1), 453-458. doi: 10.22092/ari.2022.359755.2474
H Karim Abdul-Husseein; K Akram Al- Akkam; M Karim Abdul-Husseein; H Abdul-Amir Makki Al-Hindy. "Liver Function Abnormalities in COVID-19 Patients and their Association with Age and Sex: a Cross-Sectional Study". سامانه مدیریت نشریات علمی, 78, 1, 1401, 453-458. doi: 10.22092/ari.2022.359755.2474
Karim Abdul-Husseein, H, Akram Al- Akkam, K, Karim Abdul-Husseein, M, Abdul-Amir Makki Al-Hindy, H. (1401). 'Liver Function Abnormalities in COVID-19 Patients and their Association with Age and Sex: a Cross-Sectional Study', سامانه مدیریت نشریات علمی, 78(1), pp. 453-458. doi: 10.22092/ari.2022.359755.2474
Karim Abdul-Husseein, H, Akram Al- Akkam, K, Karim Abdul-Husseein, M, Abdul-Amir Makki Al-Hindy, H. Liver Function Abnormalities in COVID-19 Patients and their Association with Age and Sex: a Cross-Sectional Study. سامانه مدیریت نشریات علمی, 1401; 78(1): 453-458. doi: 10.22092/ari.2022.359755.2474

Liver Function Abnormalities in COVID-19 Patients and their Association with Age and Sex: a Cross-Sectional Study

Archives of Razi Institute
مقاله 56، دوره 78، شماره 1، فروردین و اردیبهشت 2023، صفحه 453-458    اصل مقاله (415 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2022.359755.2474
نویسندگان
H Karim Abdul-Husseein1؛ K Akram Al- Akkam2؛ M Karim Abdul-Husseein3؛ H Abdul-Amir Makki Al-Hindy* 4
1Department of Clinical Pharmacy, College of Pharmacy, University of Babylon, Babylon, Iraq
2Department of Clinical Pharmacy, AlSafwa University College, Babylon, Iraq
3Merjan Medical City, Babylon Health Directorate, Iraq
4Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Babylon, Iraq
چکیده
In December 2019, the onset of an unidentified disease known as pneumonia for an unknown reason occurred in Wuhan city, China. Liver dysfunction has occurred in COVID-19-infected patients. The current study investigated liver function abnormalities in COVID-19 infected patients and their relationship with age and sex. A cross-section study was designed and conducted at Al-Hakeem hospital in Al-Najaf city in Iraq. This study comprised 167 patients with SARS-CoV-2 confirmation using real-time polymerase chain reaction. Liver function test results were compared among different age groups and the two genders. The analysis of categorical variables was achieved via the Chi-square test. The differences in the continuous variables between both sexes were detected via Mann–Whitney U test. A statistically significant p-value was determined to be less than 0.05. IBM SPSS software (version 26) was utilized for data analysis. Among 167 patients with COVID-19 infection, 82 (49.1 %) had abnormal liver test and 85 (50.9%) were normal (P=0.816). No significant differences were noted in liver test abnormalities among the various age groups (P=0.784). The percentages of liver function abnormalities in males and females were (68.3 %) and (37.5 %) respectively. Significant differences were detected between males and females (P=0.001). The distribution of AST and ALT between males and females was shown to be significantly different (P=0.012) and (P=0.009), respectively. The ALP (U/L) and total bilirubin (mg/dL) median values between males and females were shown to be statistically insignificant. In our study, we estimated that the risk of liver function abnormalities was not significantly different among all age groups and infected males had a higher incidence of liver dysfunction with significant differences in serum AST and ALT levels between both sexes.
کلیدواژه‌ها
COVID-19؛ Liver function abnormalities؛ Age؛ Sex
سایر فایل های مرتبط با مقاله
مراجع
  1. Abdul-Husseein HK A-AK, Bash HS, Abdul-Husseein MK. Survey of the effects of ivy leaves dry extract and bromhexine for management of cough and shortness of breath in COVID-19 infected patients. Lat Am J Pharm. 2021;40(Special issue):100-4.
  2. Hayder AA. Al-Hindy MJM, Hayder O. Hashim BCG Vaccine in Preventing COVID-19 Epidemic Had to be Reviewed: Correlation does not imply causation. Aust J Basic Appl Sci. 2020;14(11):58-63.
  3. Amer Fadhil Alhaideri WAA, Azher Nema Mohammed Al-Agam, Mahir Abdulkadhum Alzughaibi, Hayder Abdul-Amir M. Al-Hindy, Mazin J. Mousa Hypovitaminosis D is A Biological Vulnerability for Depressive Symptoms in Major Depression at the era of COVID-19 Outbreak. Clin Schizophr Relat Psychoses. 2022;5.
  4. WHO. World Health Organization Pneumonia of unknown cause — China. Available from: https://wwwwhoint/csr/don/05-january-2020-pneumonia-of unknown-cause china/e. 2020.
  5. Lotfi M HM, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta 2020;508:254–66.
  6. Wang Y WY, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2019;92(6):568–76.
  1. Garrido I LR, Macedo G. Review article: COVID-19 and liver disease what we know on May 1 2020. Aliment Pharmacol Ther. 2020;52:267–75.
  2. Chau TN LK, Yao H, Tsang TY, Chow TC, Yeung YC, et al. SARS associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39:302–10.
  3. Nardo AD, Schneeweiss‐Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID‐19. Liver International. 2021 Jan;41(1):20-32.
  4. Chen N ZM, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.
  5. Xu Z SL, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2.
  6. Feng G ZK, Yan Q-Q, Rios RS, Targher G, Byrne C, et al. COVID-19, and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol. 2020;8(1):18-24.
  7. Cai Q HD, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020;73(3):566–74.
  8. Kaushik A WS, Baba MA, Agarwal AK. Prevalence of abnormal liver function tests in COVID-19 patients at a tertiary care centre. J Assoc Phys India. 2020;68(8):73-5.
  9. Kumar A KP, Dungdung A, Gupta AK, Anurag A. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients. Diabetes Metab Syndr: Clin Res Rev. 2020;14:1951-4.
  10. Hao S-R ZS-Y, Lian J-S, Jin X, Ye C-Y, Cai H, et al. Liver enzyme elevation in coronavirus disease 2019: a multicenter, retrospective, cross-sectional study. Am J Gastroenterol 2020;00:1–9.
  11. Arnold CMH. Clinical biochemistry and metabolic medicine. 8th ed. 2012. 8th p.
  12. Abdul-Husseein MK A-HH, AL- Akkam KA, Bash HS. Assessing the possible impact of patient’s demographic data on coronavirus symptoms. Arch Venez Farmacol Ter. 2021;40(8):806-10.
  1. Xu H ZL, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the   epithelial cells of oral mucosa. Int J Oral Sci 2020;12(8).
  2. Guan GW GL, Wang JW, Wen XJ, Mao TH, Peng SW, et al. Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus infected pneumonia. Zhonghua Gan Zang Bing Za Zhi. 8(2):100-6.
  1. Holshue ML DC, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. , 10.1056/NEJMoa2001191. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020;382:929–36.
آمار
تعداد مشاهده مقاله: 1,059
تعداد دریافت فایل اصل مقاله: 186


counter
سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب